Skip to Main Content

Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin (AURORA2)

Conditions

Diseases of the Kidney & Urinary Tract

Phase III

What is the purpose of this trial?

Brief Summary:

The purpose of this study is assess the long-term safety and tolerability of voclosporin compared with placebo for up to an additional 24 months following completion of treatment in the AURORA 1 study in subjects with lupus nephritis (LN).

  • Trial with
    Aurinia Pharmaceuticals, Inc.
  • Start Date
    04/01/2019
  • End Date
    08/30/2021
Trial Image

For more information about this study, contact:

Allison Ready

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

  • Last Updated
    04/08/2019
  • Study HIC
    #2000024835